-
EP1339399
European procedure
Extract from the Register of European Patents
EP About this file: EP1339399
| EP1339399 - COMBINATIONS OF DRUGS (E.G., CHLORPROMAZINE AND PENTAMIDINE) FOR THE TREATMENT OF NEOPLASTIC DISORDERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.01.2007 Database last updated on 20.07.2024 | Most recent event Tooltip | 09.11.2007 | Change - lapse in a contracting state State(s) deleted from list of lapses: IT | published on 12.12.2007 [2007/50] | Applicant(s) | For all designated states CombinatoRx, Incorporated 650 Albany Street Boston, MA 02118 / US | [2006/09] |
| Former [2003/36] | For all designated states Combinatorx, Incorporated 650 Albany Street Boston, MA 02118 / US | Inventor(s) | 01 /
BORISY, Alexis 31 Revere Street, Apartment 2 Boston, MA 02114 / US | 02 /
KEITH, Curtis 42 Rutland Square, Apartment 2 Boston, MA 02118 / US | 03 /
FOLEY, Michael, A. 93 Wolcott Road Chestnut Hill, MA 02467 / US | 04 /
STOCKWELL, Brent, R. 59 West Cedar Street, Apartment 4 Boston, MA 02114 / US | [2003/36] | Representative(s) | Gervasi, Gemma Notarbartolo & Gervasi GmbH Bavariaring 21 80336 München / DE | [N/P] |
| Former [2003/36] | Gervasi, Gemma, Dr. Notarbartolo & Gervasi GmbH, Bavariaring 21 80336 München / DE | Application number, filing date | 01994213.5 | 30.10.2001 | [2003/36] | WO2001US47959 | Priority number, date | US20000706929 | 06.11.2000 Original published format: US 706929 | [2003/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02058684 | Date: | 01.08.2002 | Language: | EN | [2002/31] | Type: | A2 Application without search report | No.: | EP1339399 | Date: | 03.09.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.08.2002 takes the place of the publication of the European patent application. | [2003/36] | Type: | B1 Patent specification | No.: | EP1339399 | Date: | 01.03.2006 | Language: | EN | [2006/09] | Search report(s) | International search report - published on: | EP | 17.04.2003 | Classification | IPC: | A61K31/155, A61P35/00 | [2005/29] | CPC: |
A61K45/06 (EP,US);
A61K31/5415 (EP,KR,US);
A61K31/155 (EP,US);
A61K31/495 (EP,US);
A61K31/54 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP)
(-)
| C-Set: |
A61K31/155, A61K2300/00 (US,EP);
A61K31/495, A61K2300/00 (US,EP);
A61K31/5415, A61K2300/00 (EP,US);
A61K31/54, A61K2300/00 (US,EP); |
| Former IPC [2003/36] | A61K31/155 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/36] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ARZNEIMITTELKOMBINATIONEN (Z.B. CHLORPROMAZIN UND PENTAMIDIN) ZUR THERAPIE VON NEOPLASTISCHEN ERKRANKUNGEN | [2003/36] | English: | COMBINATIONS OF DRUGS (E.G., CHLORPROMAZINE AND PENTAMIDINE) FOR THE TREATMENT OF NEOPLASTIC DISORDERS | [2003/36] | French: | COMBINAISONS DE MEDICAMENTS (PAR EXEMPLE DE CHLORPROMAZINE ET DE PENTAMIDINE) POUR LE TRAITEMENT DE TROUBLES NEOPLASIQUES | [2003/36] | Entry into regional phase | 05.06.2003 | National basic fee paid | 05.06.2003 | Designation fee(s) paid | 05.06.2003 | Examination fee paid | Examination procedure | 30.05.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 05.06.2003 | Amendment by applicant (claims and/or description) | 05.06.2003 | Examination requested [2003/36] | 03.02.2004 | Despatch of a communication from the examining division (Time limit: M06) | 02.08.2004 | Reply to a communication from the examining division | 12.08.2004 | Despatch of a communication from the examining division (Time limit: M04) | 23.09.2004 | Reply to a communication from the examining division | 18.01.2005 | Despatch of a communication from the examining division (Time limit: M04) | 27.05.2005 | Reply to a communication from the examining division | 02.08.2005 | Communication of intention to grant the patent | 01.12.2005 | Fee for grant paid | 01.12.2005 | Fee for publishing/printing paid | Opposition(s) | 04.12.2006 | No opposition filed within time limit [2007/06] | Fees paid | Renewal fee | 23.10.2003 | Renewal fee patent year 03 | 25.10.2004 | Renewal fee patent year 04 | 27.10.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2007/50] |
| Former [2007/37] | IT | 01.03.2006 | Cited in | International search | [XY]CH681780 (PATRINOVE, et al) [X] 10 * claims 1,4,6 * [Y] 1-9,11-20; | [XY] - HAIT W N ET AL, "Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine.", CANCER CHEMOTHERAPY AND PHARMACOLOGY, (1989) 23 (6) 358-62. JOURNAL CODE: 7806519. ISSN: 0344-5704., Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510., XP001095611 [X] 10 * abstract * [Y] 1-9,11-20 DOI: http://dx.doi.org/10.1007/BF00435836 | [XY] - DANIEL D. VON HOFF, "Use of Daunorubicin in Patients With Solid Tumors", SEMINARS IN ONCOLOGY, (1984), vol. 11, no. 4, pages 23 - 27, XP001098570 [X] 10 * page 25, column L * [Y] 1-9,11-20 | [Y] - D.R. MAKULU ET AL, "Effects of Pentamidine Upon Murine Leukemia and the Walker 256 Carcinoma (W256)", THE PHARMACOLOGIST, (1974), vol. 16, no. 2, page abs. no. 105, XP001095144 [Y] 1-9,11-20 * abstract * | [Y] - SHIN-ICHI AKIYAMA ET AL, "Circumvention of Multiple-Drug Resistance in Human Cancer Cells by Thioridazine, Trifluoperazine, and Chlorpromazine", JOURNAL OF THE NATIONAL CANCER INSTITUTE, (1986), vol. 76, no. 5, pages 839 - 844, XP001098572 [Y] 1-9,11-20 * abstract * | [Y] - RADERER M. ET AL, "Clinical trials of agents that reverse multidrug resistance: A literature review.", CANCER, (1993) 72/12 (3553-3563)., XP001095140 [Y] 1-9,11-20 * page 3559 * | Examination | - VALERIOTE F.; LIN H.-S., "SYNERGISTIC INTERACTION OF ANTICANCER AGENTS: A CELLULAR PERSPECTIVE", CANCER CHEMOTHERAPY REPORTS, (197509), vol. 59, no. 5, pages 895 - 900, XP009019750 |